NR3C1 and neoplasm: Both control and Nr3c1-deficient B16 cells exhibited identical growth in vivo (Figure 2E and Supplemental Figure 2F), demonstrating that tumor-derived glucocorticoids do not signal in an autocrine manner to promote growth.